The BENEFICIAL Study: Evaluating the Efficacy and Safety of Alagebrium (ALT-711) in Patients With Chronic Heart Failure (BENEFICIAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00516646
Recruitment Status : Completed
First Posted : August 15, 2007
Last Update Posted : January 13, 2010
Information provided by:
Synvista Therapeutics, Inc

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2009
  Actual Study Completion Date : October 2009
Thohan V, Koerner MM, Pratt CM, Torre GA. Improvements in Diastolic Function Among Patients with Advanced Systolic Heart Failure Utilizing Alagebrium (an Oral Advanced Glycation End-product Cross-link Breaker). American Heart Association Scientific Sessions . 2005. Ref Type: Abstract

Publications automatically indexed to this study by Identifier (NCT Number):